Literature DB >> 3745215

Regulation of oncogene expression in cultured aortic smooth muscle cells. Post-transcriptional control of c-myc mRNA.

M S Kindy, G E Sonenshein.   

Abstract

Proliferation of normally quiescent vascular smooth muscle cells plays a major role in the development of an atherosclerotic lesion. Since cellular homologues of oncogenes have been implicated in the control of normal cell proliferation, we have analyzed the regulation of expression of two proto-oncogenes (c-fos and c-myc) in primary cultures of calf aortic smooth muscle cells during the transition from quiescence to proliferation. Quiescent (serum-deprived) smooth muscle cells were stimulated to proliferative by serum addition. DNA synthesis began 12 h post-serum addition and peaked between 16 and 20 h. Following addition of serum, c-fos mRNA levels increased rapidly from an undetectable amount to the maximal level at 30 min after serum addition and then rapidly returned to the levels found in quiescent cells. Changes in the rate of c-fos gene transcription, as measured by nuclear "runoff" assays, paralleled the alterations in mRNA levels, indicating that regulation of c-fos was at the level of mRNA synthesis. The mRNA for the c-myc oncogene was expressed at a detectable level in quiescent cells, peaked in abundance at approximately 2 h after stimulation, and then returned to the level found in quiescent cells. No significant change in the rate of c-myc gene transcription was detectable over the time course. The rate of decay of c-myc mRNA following the inhibition of transcription by actinomycin D was measured at the 1- and 4-h time points and in exponentially growing cells. There was a transient stabilization of the normally labile c-myc mRNA at 1 h after serum stimulation. Thus c-myc gene expression was regulated at the level of mRNA turnover.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3745215

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Serum-inducible expression of transfected human c-myc genes.

Authors:  A Richman; A Hayday
Journal:  Mol Cell Biol       Date:  1989-11       Impact factor: 4.272

2.  Regulation of c-myc mRNA stability in vitro by a labile destabilizer with an essential nucleic acid component.

Authors:  G Brewer; J Ross
Journal:  Mol Cell Biol       Date:  1989-05       Impact factor: 4.272

3.  Independent regulation of transcription of the two strands of the c-myc gene.

Authors:  M S Kindy; J E McCormack; A J Buckler; R A Levine; G E Sonenshein
Journal:  Mol Cell Biol       Date:  1987-08       Impact factor: 4.272

Review 4.  mRNA stability in mammalian cells.

Authors:  J Ross
Journal:  Microbiol Rev       Date:  1995-09

5.  Molecular cloning of a diverged homeobox gene that is rapidly down-regulated during the G0/G1 transition in vascular smooth muscle cells.

Authors:  D H Gorski; D F LePage; C V Patel; N G Copeland; N A Jenkins; K Walsh
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

6.  Heparin inhibits c-fos and c-myc mRNA expression in vascular smooth muscle cells.

Authors:  L A Pukac; J J Castellot; T C Wright; B L Caleb; M J Karnovsky
Journal:  Cell Regul       Date:  1990-04

7.  Stability of human follicle-stimulating hormone receptor mRNA in stably transfected cells.

Authors:  C Zhu; H Tian
Journal:  J Tongji Med Univ       Date:  2001

8.  Mouse mammary tumor virus c-rel transgenic mice develop mammary tumors.

Authors:  Raphaëlle Romieu-Mourez; Dong W Kim; Sang Min Shin; Elizabeth G Demicco; Esther Landesman-Bollag; David C Seldin; Robert D Cardiff; Gail E Sonenshein
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

9.  Abundant expression of parathyroid hormone-related protein in primary rat aortic smooth muscle cells accompanies serum-induced proliferation.

Authors:  T Hongo; J Kupfer; H Enomoto; B Sharifi; D Giannella-Neto; J S Forrester; F R Singer; D Goltzman; G N Hendy; C Pirola
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

10.  Interleukin 1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids.

Authors:  P Libby; S J Warner; G B Friedman
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.